Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Qiu, Xiangguo ^a   Audet, Jonathan ^b   Wong, Gary ^b   Fernando, Lisa ^a   Bello, Alexander ^b   Pillet, Stéphane ^a   Alimonti, Judie B ^a,b   Kobinger, Gary P ^a,b,c  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MACACA FASCICULARIS; MALE; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; MACACA FASCICULARIS; MALE; VIRAL ENVELOPE PROTEINS;

EID: 84889562469     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03365     Document Type: Article

References (29)

1. Sanchez, A., Geisbert, T. W. & Feldmann, H. in Fields Virology (eds Knipe, D.M., Howley, P. M.,Griffin, D. E., Lamb, M. A. et al.) 1409-1448 (Lippincott, Williams. & Wilkins, 2007)
2. Kobinger, G. P. et al. Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J. Infect. Dis. 204, 200-208 (2011)
3. Falzarano, D., Geisbert, T. W. & Feldmann, H. Progress in filovirus vaccine development: Evaluating the potential for clinical use. Expert Rev. Vaccines 10, 63-77 (2011)
4. Friedrich, B. M. et al. Potential Vaccines and Post-Exposure Treatments for Filovirus Infections. Viruses 4, 1619-1650 (2012)
5. Jones, S. M. et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 11, 786-790 (2005) (Pubitemid 41021212)
6. Feldmann, H. et al. Effective post-exposure treatment of Ebola infection. PLoS Pathog. 3, e2 (2007)
7. Geisbert, T. W. et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study. Lancet 375, 1896-1905 (2010)
8. Warren, T. K. et al. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat. Med. 16, 991-994 (2010)
9. Macias, W. L. & Nelson, D. R. Severe protein C deficiency predicts early death in severe sepsis. Crit. Care Med. 32, S223-8 (2004)
10. Hensley, L. E. et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J. Infect. Dis. 196 Suppl 2, S390-9 (2007)
11. Geisbert, T. W. et al. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J. Infect. Dis. 188, 1618-1629 (2003) (Pubitemid 38010671)
12. Bernard, G. R. et al. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit. Care Med. 29, 2051-2059 (2001) (Pubitemid 33063531)
13. Geisbert, T. W. et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: A study in rhesus monkeys. Lancet 362, 1953-1958 (2003) (Pubitemid 37548417)
14. Emond, R. T., Evans, B., Bowen, E. T. & Lloyd, G. A case of Ebola virus infection. Br. Med. J. 2, 541-544 (1977) (Pubitemid 8160914)
15. Mupapa, K. et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J. Infect. Dis. 179 Suppl 1, S18-23 (1999) (Pubitemid 29091378)
16. Jahrling, P. B. et al. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch. Virol. Suppl. 11, 135-140 (1996) (Pubitemid 126446186)
17. Jahrling, P. B. et al. Evaluation of immune globulin and recombinant interferonalpha2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179 Suppl 1, S224-34 (1999)
18. Oswald, W. B. et al.Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog. 3, e9 (2007)
19. Dye, J. M. et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl. Acad. Sci. U. S. A. 109, 5034-5039 (2012)
20. Marzi, A. et al. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One 7, e36192 (2012)
21. Olinger, G. G. Jr. et al. Delayed treatment of Ebola virus infection with plantderived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 109, 18030-18035 (2012)
22. Qiu, X. et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4, 138ra81 (2012)
23. Wu, J. Q. et al. Pre-and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha. Virology 369, 206-213 (2007) (Pubitemid 350047475)
24. Qiu, X. et al. mAbs and Ad-Vectored IFN-alpha Therapy Rescue Ebola-Infected Nonhuman Primates When Administered After the Detection of Viremia and Symptoms. Sci. Transl. Med. 5, 207ra143 (2013)
25. Wong, G. et al. Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates. Sci. Transl. Med. 4, 158ra146 (2012)
26. Wauquier, N., Becquart, P., Padilla, C., Baize, S. & Leroy, E. M. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop. Dis. 4, e837 (2010)
27. Sullivan, N. J., Martin, J. E., Graham, B. S. & Nabel, G. J. Correlates of protective immunity for Ebola vaccines: Implications for regulatory approval by the animal rule. Nat. Rev. Microbiol. 7, 393-400 (2009)
28. Mohan, G. S., Li, W., Ye, L., Compans, R. W. & Yang, C. Antigenic subversion: A novel mechanism of host immune evasion by Ebola virus. PLoS Pathog. 8, e1003065 (2012)
29. Qiu, X. et al. Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS One 4, e5547 (2009)